You just read:

DURECT Corporation to Present Preliminary Data from the Ongoing DUR-928 Alcoholic Hepatitis Phase 2a Trial and Report First Quarter 2019 Financial Results

News provided by

DURECT Corporation

May 03, 2019, 13:26 ET